Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
JACC Cardiovasc Interv. 2021 Dec 27;14(24):2670-2681. doi: 10.1016/j.jcin.2021.08.038. Epub 2021 Nov 24.
The aim of this study was to compare the incidence and prognostic significance of prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR) according to racial groups.
PPM after TAVR may be of more concern in Asian populations considering their relatively small annular and valve sizes compared with Western populations.
TP-TAVR (Transpacific TAVR Registry) was an international multicenter cohort study of patients with severe aortic stenosis who underwent TAVR in the United States and South Korea from January 2015 to November 2019. PPM was defined as moderate (0.65-0.85 cm/m) or severe (<0.65 cm/m) at the indexed effective orifice area. The primary outcome was a composite of death, stroke, or rehospitalization at 1 year.
Among 1,101 eligible patients (533 Asian and 569 non-Asian), the incidence of PPM was significantly lower in the Asian population (33.6%; moderate, 26.5%; severe, 7.1%) than in the non-Asian population (54.5%; moderate, 29.8%; severe, 24.7%). The 1-year rate of the primary outcome was similar between the PPM and non-PPM groups (27.5% vs 28.1%; P = 0.69); this pattern was consistent between Asian (25.4% vs 25.2%; P = 0.31) and non-Asian (28.7% vs 32.1%; P = 0.97) patients. After multivariable adjustment, the risk for the primary outcome did not significantly differ between the PPM and non-PPM groups in the overall population (HR: 0.95; 95% CI: 0.74-1.21), in Asian patients (HR: 1.07; 95% CI: 0.74-1.55), and in non-Asian patients (HR: 0.86; 95% CI: 0.63-1.19).
In this study of patients with severe aortic stenosis who underwent TAVR, the incidence of PPM was significantly lower in Asian patients than in non-Asian patients. The 1-year risk for the primary composite outcome was similar between the PPM and non-PPM groups regardless of racial group. (Transpacific TAVR Registry [TP-TAVR]; NCT03826264).
本研究旨在比较经导管主动脉瓣置换术(TAVR)后不同种族患者的假体-患者不匹配(PPM)发生率及其预后意义。
考虑到亚洲人群的瓣环和瓣膜相对较小,与西方人群相比,TAVR 后 PPM 可能更令人关注。
TP-TAVR(泛太平洋 TAVR 注册研究)是一项国际性多中心队列研究,纳入了 2015 年 1 月至 2019 年 11 月期间在美国和韩国接受 TAVR 的严重主动脉瓣狭窄患者。PPM 定义为指数有效瓣口面积时中度(0.65-0.85cm/m)或重度(<0.65cm/m)。主要结局为 1 年时死亡、卒中和再住院的复合终点。
在 1101 名符合条件的患者(亚洲患者 533 名,非亚洲患者 569 名)中,亚洲人群的 PPM 发生率明显低于非亚洲人群(33.6%,中度 26.5%,重度 7.1%)。PPM 组和非 PPM 组的 1 年主要结局发生率相似(27.5% vs 28.1%;P=0.69),这一模式在亚洲患者(25.4% vs 25.2%;P=0.31)和非亚洲患者(28.7% vs 32.1%;P=0.97)中均一致。多变量调整后,总体人群、亚洲患者和非亚洲患者中 PPM 组与非 PPM 组的主要结局风险无显著差异(HR:0.95;95%CI:0.74-1.21;HR:1.07;95%CI:0.74-1.55;HR:0.86;95%CI:0.63-1.19)。
在这项接受 TAVR 的严重主动脉瓣狭窄患者研究中,亚洲患者的 PPM 发生率明显低于非亚洲患者。无论种族,PPM 组与非 PPM 组的 1 年主要复合结局风险相似。(泛太平洋 TAVR 注册研究[TP-TAVR];NCT03826264)